Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Left main crossover stenting in a patient with severe thrombocytopenia due to aplastic anemia

    ... events for 7 months without antiplatelet/ anticoagulant therapy. Bone Marrow Diseases:  ...

    Research Article last updated 12/09/2016 - 2:08pm.

  2. Eculizumab Protects Against TE and Prolongs Survival in Patients with Paroxysmal Nocturnal Hemoglobinuria: An International PNH Registry Study

    ... were male. Half were treated with eculizumab, 28% used anticoagulant drugs (such as heparin or warfarin ), and 18% used both eculizumab and anticoagulant drugs. On average, 23 months of follow-up data were available on ...

    Research Review last updated 05/02/2016 - 9:26am.

  3. Pasireotide in Prevention of GI Toxicity

    ... continuous anticoagulation therapy. Patients who were on anticoagulant therapy must complete a washout period of at least 10 days ...

    Clinical Trial last updated 06/06/2016 - 10:41am.

  4. Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia

    ... and CYP3A4 inhibitors, and inducers. An increased anticoagulant effect has been noted in patients treated with warfarin ...

    Clinical Trial last updated 06/03/2016 - 2:24pm.